# US 2020/0003737 A1 · Dexrazoxane analytical method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0003737 A1
- Document ID: US20200003737A1
- Status: Published application
- Kind: A1
- Application number: 16/465,441
- Filed: 2017-11-30
- Published: 2020-01-02
- Earliest claimed: 2016-12-13
- Assignees: Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Applicants: Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Inventors: Xiangfeng CHEN; Hongyu CHEN; Shuaihua TIAN; Min SUN; Changjun FAN
- Web page: https://patentgrep.com/patent/US20200003737A1

## CPC

- G01N 30/06: Preparation
- C07D 241/08: with oxygen atoms directly attached to ring carbon atoms
- C07D 403/06: linked by a carbon chain containing only aliphatic carbon atoms
- G01N 2030/027: {Liquid chromatography}
- G01N 2030/8809: {analysis specially adapted for the sample}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A high performance liquid chromatography method used for dexrazoxane-related substances is provided, and in the method, a low-density bonding reversed-phase C18 chromatographic column resistant to pure water is employed; a gradient elution is carried out with mobile phase A and mobile phase B as eluents, the mobile phase A being a buffer, and the mobile phase B being an organic solvent; the volume percent of mobile phase A in eluents in a first stage of the gradient elution is not lower than 90%, and the duration of the first stage of the gradient elution ranges from 15˜30 minutes. By means of the analytical method, dexrazoxane is effectively separated from main impurities, and the qualities of the active pharmaceutical ingredients of dexrazoxane and the preparations thereof could be better controlled.

## Claims

### Claim 1

A high performance liquid chromatography method used for dexrazoxane-related substances, wherein a low-density bonding reversed-phase C18 chromatographic column resist to pure water is employed; a gradient elution is carried out with a mobile phase A and a mobile phase B as eluents, the mobile phase A being a buffer, and the mobile phase B being an organic solvent; the volume percent content of the mobile phase A in eluents in a first stage of the gradient elution is not lower than 90%, and the duration in the first stage of the gradient elution ranges from 15˜30 minutes.

### Claim 2 (depends on 1)

The analytical method of claim 1, wherein the low-density bonding reversed-phase C18 chromatographic column resist to pure water is Waters Atlantis T3 or Waters ACQUITY HSS T3.

### Claim 3 (depends on 1)

The analytical method of claim 1, wherein the buffer is selected from a buffered salt solution of 1˜50 mmol/L at a pH of 1˜6, of potassium dihydrogen phosphate, sodium dihydrogen phosphate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, diammonium hydrogen phosphate or ammonium dihydrogen phosphate; the organic solvent is selected from methanol, acetonitrile or isopropanol.

### Claim 4 (depends on 1)

The analytical method of claim 1, wherein the volume percent content of the mobile phase A in the eluents in the first stage of the gradient elution is not lower than 95%, the duration in the first stage of the gradient elution ranges from 15˜20 minutes.

### Claim 5 (depends on 1)

The analytical method of claim 1, wherein the conditions of the gradient elution are:
Time
Mobile Phase A
Mobile Phase B
(minutes)
(%)
(%)
The First
0
100
0
Stage
15
100
0
45
n
100-n
50
n
100-n
50.01
100
0
60
100
0
wherein 10≤n≤90.

### Claim 6 (depends on 1)

The analytical method of claim 1, wherein the method has the following optional chromatographic conditions:
the flow rate of the mobile phase is 0.6˜1.5 mL/min, and/or
the temperature of the chromatographic column is 5˜20° C., and/or
the ultraviolet detector is employed as the detector, with a detection wavelength of 200˜220 nm.

### Claim 7 (depends on 6)

The analytical method of claim 6, wherein the flow rate of the mobile phase is 0.8˜1.2 mL/min; the temperature of the chromatographic column is 10˜20° C.; the detection wavelength is 203˜213 nm.

### Claim 8 (depends on 1)

The analytical method of claim 1, wherein comprising four steps of the preparation of a test solution, the preparation of a control solution, the preparation of a system suitability test solution and the detection,
the preparation of the test solution comprises: taking a proper amount of dexrazoxane or dexrazoxane-containing related preparations, formulating with a diluent into a solution at a concentration of 0.5˜2 mg dexrazoxane per 1 mL, being used as the test solution;
the preparation of the control solution comprises: taking the test solution, diluting to a volume of 100 times with a diluent, being used as the control solution; the preparation of the system suitability test solution comprises: taking dexrazoxane or dexrazoxane-containing related preparations, an impurity I control, an impurity II control, an impurity III control at proper amounts, dissolving with a diluent and diluting into a solution containing dexrazoxane 0.5˜2 mg, impurity I 5˜20 g, impurity II 5˜20 g, impurity III 5˜20 g per 1 mL, and being used as the system suitability test solution;
the detection step comprises: taking 10˜20 μl of system suitability test solution, injecting it into the liquid chromatograph, the resolutions between the dexrazoxane peak and each adjacent impurity peak should meet the criteria; taking 10˜20 μl of control solution, injecting it into the liquid chromatograph, adjusting the detection sensitivity, making the peak height of the chromatographic peak of the main ingredient be 10˜20% of the full scale; precisely measuring 10˜20 μl of test solution, injecting it into the liquid chromatograph, recording the chromatogram;
wherein the diluent is a hydrochloric acid solution, the chemical structures of impurity I, impurity II, impurity III are shown as below:

### Claim 9 (depends on 8)

The analytical method of claim 8, comprising the following steps:
(1) preparation of the test solution: taking a proper amount of dexrazoxane or dexrazoxane-containing related preparations, formulating into a solution at a concentration of 0.8˜1.1 mg dexrazoxane per 1 mL with a hydrochloric acid solution, being used as the test solution;
(2) preparation of the control solution: precisely measuring the test solution prepared in the above step (1), diluting to a volume of 100 times with the hydrochloric acid solution described in (1), used as the control solution;
(3) preparation of the system suitability test solution: taking proper amounts of dexrazoxane or dexrazoxane-containing related preparations, impurity I control, impurity II control, impurity III control, dissolving with the hydrochloric acid solution described in (1) and diluting into a solution containing dexrazoxane 0.8˜1.1 mg, impurity I 8˜12 g, impurity II 8˜12 g, impurity III 8˜12 g per 1 mL, being used as the system suitability test solution;
(4) detection: taking the system suitability test solution 10 μl, injecting it into the liquid chromatograph, the resolutions between the dexrazoxane peak and each adjacent impurity peak should meet the criteria; taking the control solution 10 μl, injecting it into the liquid chromatograph, adjusting the detection sensitivity, making the peak height of the chromatographic peak of the main ingredient be 10˜20% of the full scale; precisely measuring 10 μl of test solution, injecting it into the liquid chromatograph, recording the chromatogram.

### Claim 10 (depends on 1)

The analytical method of claim 1, being useful for the detection of dexrazoxane and dexrazoxane-containing preparations.

### Claim 11 (depends on 2)

The analytical method of claim 2, wherein the low-density bonding reversed-phase C18 chromatographic column resist to pure water is Waters Atlantis T3.

### Claim 12 (depends on 3)

The analytical method of claim 3, wherein the buffer is a potassium dihydrogen phosphate solution of 5˜15 mmol/L at apH of 3.5˜5.5, the organic solvent is methanol or acetonitrile.

### Claim 13 (depends on 3)

The analytical method of claim 3, wherein the buffer is a potassium dihydrogen phosphate solution of 8˜12 mmol/L at apH of 4.5˜5, the organic solvent is methanol.

### Claim 14 (depends on 5)

The analytical method of claim 5, wherein 50≤n≤80.

### Claim 15 (depends on 5)

The analytical method of claim 5, wherein 60≤n≤80.
